Primary prevention of variceal haemorrhage: A pharmacological approach

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 46, Issue 3, Pages (March 2007)

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 50, Issue 4, Pages (April 2009)

Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi.

Anticoagulation in chronic liver disease

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Thrombocytopenia With Abnormal Liver Function Tests

Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou

Volume 61, Issue 6, Pages (December 2014)

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

NS5A inhibitors in the treatment of hepatitis C

Immigration and viral hepatitis

Marcus-Alexander Wörns, Peter Robert Galle Journal of Hepatology

Volume 66, Issue 1, Pages 1-4 (January 2017)

The evidence supports a viral aetiology for primary biliary cirrhosis

Living donor liver transplantation: is the hype over?

European Association for the Study of the Liver Journal of Hepatology

Volume 69, Issue 2, Pages (August 2018)

The place of downstaging for hepatocellular carcinoma

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

Yoji Ishizu, MD, PhD, Masatoshi Ishigami, MD, PhD

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

European Association for the Study of the Liver Journal of Hepatology

Hepatitis C core protein – The “core” of immune deception?

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 62, Issue 3, Pages (March 2015)

Darius Moradpour, Arash Grakoui, Michael P. Manns

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Use of hemospray for non-variceal esophageal bleeding in an infant

Volume 41, Issue 4, Pages (October 2004)

The changing role of beta-blocker therapy in patients with cirrhosis

Volume 57, Issue 5, Pages (November 2012)

Hepatology may have problems with putative surrogate outcome measures

Volume 50, Issue 4, Pages (April 2009)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Paul C. Adams, James C. Barton Journal of Hepatology

Immigration and viral hepatitis

Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability Markus Cornberg,

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

Volume 64, Issue 6, Pages (June 2016)

Esophageal variceal bleeding: Primary prophylaxis

Volume 63, Issue 1, Pages (July 2015)

The use of hemospray in portal hypertensive bleeding; a case series

Chronic hepatitis B in children and adolescents

Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice Paolo Angeli, Pere Gines

Thrombocytopenia With Abnormal Liver Function Tests

Volume 66, Issue 4, Pages (April 2017)

Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials? Jingzhi Cai, Wengang Guo, Chuangye.

New trials and results in systemic treatment of HCC

Liver transplantation in children

Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi

News & Notes Journal of Allergy and Clinical Immunology

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Volume 139, Issue 6, Pages e1 (December 2010)

Volume 50, Issue 1, Pages 4-6 (January 2009)

Thierry Gustot, Rajiv Jalan Journal of Hepatology

M. Mazen Jamal, Jason B. Samarasena, Mehrtash Hashemzadeh, Kenneth J

Presentation transcript:

Primary prevention of variceal haemorrhage: A pharmacological approach Andrew K. Burroughs, Emmanuel A. Tsochatzis, Christos Triantos Journal of Hepatology Volume 52, Issue 6, Pages 946-948 (June 2010) DOI: 10.1016/j.jhep.2010.02.015 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Forest plots for (A) first bleeding (B) mortality in patients with cirrhosis and varices receiving either endoscopic banding ligation or non-selective beta-blockers in randomised clinical trials (BB: beta-blockers, EBL: endoscopic band ligation). Journal of Hepatology 2010 52, 946-948DOI: (10.1016/j.jhep.2010.02.015) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions